Implementing the ICH E6(R3) guidelines requires organizations to adopt a proportionate approach to risk management, focusing on protocol-specific critical quality factors to enhance clinical trial quality. This involves setting acceptable risk thresholds, evaluating deviations, and proactively addressing potential issues.
